検索
Arcellx Inc
ACLXウォッチリストに追加
115.070USD
0.0000.00%
終値 06/30, 16:00（ET）15分遅れの株価
6.73B時価総額
損失額直近12ヶ月PER
株主
更新時刻: Sun, May 10
更新時刻: Sun, May 10
株主統計
種類
株主統計
株主統計
比率
Gilead Sciences, Inc
11.49%
Vanguard Capital Management, LLC
4.15%
Vanguard Portfolio Management, LLC
4.15%
State Street Investment Management (US)
3.42%
T. Rowe Price Associates, Inc.
2.69%
他の
74.10%
株主統計
株主統計
比率
Gilead Sciences, Inc
11.49%
Vanguard Capital Management, LLC
4.15%
Vanguard Portfolio Management, LLC
4.15%
State Street Investment Management (US)
3.42%
T. Rowe Price Associates, Inc.
2.69%
他の
74.10%
種類
株主統計
比率
Investment Advisor
21.80%
Investment Advisor/Hedge Fund
12.92%
Corporation
11.49%
Hedge Fund
8.43%
Research Firm
2.86%
Venture Capital
1.07%
Bank and Trust
0.47%
Pension Fund
0.18%
Sovereign Wealth Fund
0.03%
他の
40.75%
機関投資家保有株
更新時刻: Wed, Apr 1
更新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q1
483
22.60M
38.64%
-31.29M
2025Q4
441
60.19M
107.73%
+3.27M
2025Q3
457
56.92M
115.34%
-1.91M
2025Q2
440
55.23M
110.30%
-248.28K
2025Q1
433
55.56M
106.71%
-3.07M
2024Q4
424
53.15M
105.55%
+1.98M
2024Q3
391
50.27M
106.69%
-1.02M
2024Q2
368
52.42M
103.43%
+3.23M
2024Q1
351
49.13M
103.29%
-5.40M
2023Q4
314
49.14M
109.15%
-782.40K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Gilead Sciences, Inc
6.72M
11.49%
--
--
Feb 23, 2026
State Street Investment Management (US)
2.00M
3.42%
+472.48K
+30.96%
Dec 31, 2025
T. Rowe Price Associates, Inc.
1.57M
2.69%
+344.40K
+28.00%
Dec 31, 2025
Citadel Advisors LLC
1.50M
2.57%
+478.77K
+46.87%
Dec 31, 2025
JP Morgan Asset Management
1.23M
2.1%
+578.50K
+89.01%
Dec 31, 2025
Geode Capital Management, L.L.C.
958.06K
1.64%
+31.75K
+3.43%
Dec 31, 2025
Janus Henderson Investors
919.58K
1.57%
-94.34K
-9.30%
Dec 31, 2025
Woodline Partners LP
737.82K
1.26%
+496.44K
+205.66%
Dec 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Genomics Immunology and Healthcare ETF
4.98%
Tema Oncology ETF
4.19%
ALPS Medical Breakthroughs ETF
1.96%
Harbor Human Capital Factor US Small Cap ETF
1.38%
WisdomTree BioRevolution Fund
1.13%
State Street SPDR S&P Biotech ETF
1.08%
Virtus LifeSci Biotech Clinical Trials ETF
0.92%
iShares Health Innovation Active ETF
0.75%
Direxion Daily S&P Biotech Bull 3X Shares
0.67%
ProShares Ultra Nasdaq Biotechnology
0.49%
詳細を見る
iShares Genomics Immunology and Healthcare ETF
比率4.98%
Tema Oncology ETF
比率4.19%
ALPS Medical Breakthroughs ETF
比率1.96%
Harbor Human Capital Factor US Small Cap ETF
比率1.38%
WisdomTree BioRevolution Fund
比率1.13%
State Street SPDR S&P Biotech ETF
比率1.08%
Virtus LifeSci Biotech Clinical Trials ETF
比率0.92%
iShares Health Innovation Active ETF
比率0.75%
Direxion Daily S&P Biotech Bull 3X Shares
比率0.67%
ProShares Ultra Nasdaq Biotechnology
比率0.49%
